Fotios Michelis

Refined hepatic grading system in chronic graft-versus-host disease improves prognostic risk stratification of long-term outcomes.

Authors:

Igor Novitzky-Basso Saud AlHayli Elizabeth Shin Ivan Pasic Zeyad Al-Shaibani Wilson Lam Arjun Law Fotios Michelis Armin Gerbitz Auro Viswabandya Jeffrey H Lipton Rajat Kumar Jonas Mattsson Dennis Dong Hwan Kim

Eur J Haematol 2021 Jan 9. Epub 2021 Jan 9.

Department of Medical Oncology and Hematology, Hans Messner Allogeneic Stem Cell Transplant Program, Princess Margaret Cancer Centre, Toronto, ON, Canada.

View Article and Find Full Text PDF

January 2021

Post-transplant ferritin level predicts outcomes after allogeneic hematopoietic stem cell transplant, independent from pre-transplant ferritin level.

Authors:

Warren Fingrut Arjun Law Wilson Lam Fotios V Michelis Auro Viswabandya Jeffrey H Lipton Rajat Kumar Jonas Mattsson Dennis Dong Hwan Kim

Ann Hematol 2021 Mar 7;100(3):789-798. Epub 2021 Jan 7.

Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.

View Article and Find Full Text PDF

March 2021

Comorbidity profile of adult survivors at 20 years following allogeneic hematopoietic cell transplantation.

Authors:

Ayesh K Seneviratne Clare Wright Wilson Lam Jeffrey H Lipton Fotios V Michelis

Eur J Haematol 2021 Feb 17;106(2):241-249. Epub 2020 Nov 17.

Hans Messner Allogeneic Transplant Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.

View Article and Find Full Text PDF

February 2021

Fresh vs. frozen allogeneic peripheral blood stem cell grafts: A successful timely option.

Authors:

Ahmad S Alotaibi Shruti Prem Shiyi Chen Jeffrey H Lipton Dennis D Kim Auro Viswabandya Rajat Kumar Wilson Lam Arjun D Law Jonas Mattsson Fotios V Michelis

Am J Hematol 2021 02 10;96(2):179-187. Epub 2020 Nov 10.

Hans Messner Allogeneic Transplant Program, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada.

View Article and Find Full Text PDF

February 2021

Outcomes of adult patients with acute myeloid leukemia and unsuccessful cytogenetic analysis undergoing allogeneic hematopoietic stem cell transplantation.

Authors:

Ram Vasudevan Nampoothiri Shiyi Chen Ivan Pasic Zeyad Al-Shaibani Wilson Lam Fotios V Michelis Dennis Dong Hwan Kim Auro Viswabandya Armin Gerbitz Jeffrey Howard Lipton Rajat Kumar Jonas Mattsson Arjun Datt Law

Hematol Oncol Stem Cell Ther 2020 Oct 8. Epub 2020 Oct 8.

Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Center, University of Toronto, Toronto, Ontario, Canada. Electronic address:

View Article and Find Full Text PDF

October 2020

Prolactin, a potential biomarker for chronic GVHD activity.

Authors:

Maria Queralt Salas Shereen Ezzat Wilson Lam Arjun Datt Law Ivan Pasic Fotios V Michelis Dennis Dong Hwan Kim Armin Gerbitz Zeyad Al-Shaibani Auro Viswabandya Rajat Kumar Jonas Mattsson Jeffrey Howard Lipton

Eur J Haematol 2021 Feb 26;106(2):158-164. Epub 2020 Oct 26.

Section of Medical Oncology and Hematology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.

View Article and Find Full Text PDF

February 2021

Effect of donor age and kinship on outcomes in haplo-identical stem cell transplantation may be modulated by GVHD prophylaxis strategies.

Authors:

Shruti Prem Mats Remberger Maria Queralt Salas Zeyad Al-Shaibani Wilson Lam Arjun Datt Law Dennis Dong Hwan Kim Fotios V Michelis Jeffrey Howard Lipton Jonas Mattsson Rajat Kumar Cynthia Ellison Auro Viswabandya

Bone Marrow Transplant 2020 Aug 14. Epub 2020 Aug 14.

Department of Medicine, Section of Medical Oncology and Hematology, University of Toronto, Toronto, ON, Canada.

View Article and Find Full Text PDF

August 2020

High incidence but low mortality of EBV-reactivation and PTLD after alloHCT using ATG and PTCy for GVHD prophylaxis.

Authors:

Maria Queralt Salas Shruti Prem Mats Remberger Wilson Lam Dennis Dong Hwan Kim Fotios Vasilios Michelis Zeyad Al-Shaibani Armin Gerbitz Jeffrey Howard Lipton Auro Viswabandya Rajat Kumar Deepali Kumar Jonas Mattsson Arjun Datt Law

Leuk Lymphoma 2020 12 25;61(13):3198-3208. Epub 2020 Jul 25.

Department of Medicine, Division of Medical Oncology and Hematology, University of Toronto, Toronto, ON, Canada.

View Article and Find Full Text PDF

December 2020

Pilot prospective study of Frailty and Functionality in routine clinical assessment in allogeneic hematopoietic cell transplantation.

Authors:

Maria Queralt Salas Eshetu G Atenafu Ora Bascom Leeann Wilson Wilson Lam Arjun Datt Law Ivan Pasic Dennis Dong Hwan Kim Fotios V Michelis Zeyad Al-Shaibani Armin Gerbitz Auro Viswabandya Jeffrey Howard Lipton Jonas Mattsson Shabbir M H Alibhai Rajat Kumar

Bone Marrow Transplant 2021 Jan 30;56(1):60-69. Epub 2020 Jun 30.

Department of Medicine, Section of Medical Oncology and Hematology, University of Toronto, Toronto, ON, Canada.

View Article and Find Full Text PDF

January 2021

Clinical prevalence and outcome of cardiovascular events in the first 100 days postallogeneic hematopoietic stem cell transplant.

Authors:

Rehab Alblooshi Solaf Kanfar Bridgette Lord Eshetu G Atenafu Fotios V Michelis Ivan Pasic Armin Gerbitz Zeyad Al-Shaibani Auro Viswabandya Dennis Dong Hwan Kim Wilson Lam Arjun Law Jonas Mattsson Rajat Kumar Jeffrey H Lipton

Eur J Haematol 2021 Jan 13;106(1):32-39. Epub 2020 Oct 13.

Allogeneic Blood and Marrow Transplant Program, Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.

View Article and Find Full Text PDF

January 2021

Post-Transplant Cyclophosphamide Combined with Anti-Thymocyte Globulin as Graft-versus-Host Disease Prophylaxis for Allogeneic Hematopoietic Cell Transplantation in High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome.

Authors:

Wael Alanazi Shiyi Chen Jeffrey H Lipton Dennis D Kim Auro Viswabandya Rajat Kumar Wilson Lam Arjun D Law Zeyad Al-Shaibani Jonas Mattsson Fotios V Michelis

Acta Haematol 2021 19;144(1):66-73. Epub 2020 May 19.

Hans Messner Allogeneic Transplant Program, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada,

View Article and Find Full Text PDF

May 2020

Less Is More: Superior Graft-versus-Host Disease-Free/Relapse-Free Survival with Reduced-Intensity Conditioning and Dual T Cell Depletion in Acute Myelogenous Leukemia.

Authors:

Maria Queralt Salas Shiyi Chen Wilson Lam Ivan Pasic Armin Gerbitz Fotios V Michelis Dennis Dong Hwan Kim Zeyad Al-Shaibani Jeffrey Howard Lipton Jonas Mattsson Rajat Kumar Auro Viswabandya Arjun Datt Law

Biol Blood Marrow Transplant 2020 08 16;26(8):1511-1519. Epub 2020 May 16.

Hans Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada; Hematology Department, Institut Català d'Oncologia-Hospitalet, IDIBELL, Barcelona, Spain.

View Article and Find Full Text PDF

August 2020

Post-transplant cyclophosphamide combined with anti-thymocyte globulin for graft-vs-host disease prophylaxis improves survival and lowers non-relapse mortality in older patients undergoing allogeneic hematopoietic cell transplantation.

Authors:

Ivan Pasic Jeffrey H Lipton Dennis D Kim Auro Viswabandya Rajat Kumar Wilson Lam Arjun D Law Jonas Mattsson Fotios V Michelis

Ann Hematol 2020 Jun 7;99(6):1377-1387. Epub 2020 May 7.

Hans Messner Allogeneic Transplant Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.

View Article and Find Full Text PDF

June 2020

Safety of two-hour intermittent intravenous infusions of tacrolimus in the allogeneic hematopoietic stem cell transplantation unit.

Authors:

Alexander Js Bacopoulos Lina Ho Anjie Yang Pamela Ng Celina Dara David Loach Uday Deotare Fotios V Michelis Auro Viswabandya Dennis D Kim Jeffrey H Lipton Hans A Messner Santhosh Thyagu

J Oncol Pharm Pract 2021 Jan 17;27(1):33-39. Epub 2020 Mar 17.

Messner Allogeneic Transplant Program, University Health Network, Toronto, Canada.

View Article and Find Full Text PDF

January 2021

Outcomes of therapy-related acute lymphoblastic leukemia in adults after allogeneic stem cell transplantation.

Authors:

Ram Vasudevan Nampoothiri Arjun Datt Law Wilson Lam Carol Chen Zeyad Al-Shaibani David Loach Fotios V Michelis Dennis Dong Hwan Kim Jonas Mattsson Rajat Kumar Jeffrey Howard Lipton Auro Viswabandya

Eur J Haematol 2020 Jul 18;105(1):24-29. Epub 2020 Mar 18.

Hans Messner Allogeneic Blood and Marrow Transplantation Program, Princess Margaret Cancer Center, University of Toronto, Toronto, ON, Canada.

View Article and Find Full Text PDF

July 2020

Dual T-cell depletion with ATG and PTCy for peripheral blood reduced intensity conditioning allo-HSCT results in very low rates of GVHD.

Authors:

Maria Queralt Salas Shruti Prem Eshetu G Atenafu Arjun Datt Law Wilson Lam Zeyad Al-Shaibani David Loach Dennis Dong Hwan Kim Fotios V Michelis Jeffrey Howard Lipton Rajat Kumar Jonas Mattsson Auro Viswabandya

Bone Marrow Transplant 2020 09 5;55(9):1773-1783. Epub 2020 Feb 5.

Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology. Princes Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.

View Article and Find Full Text PDF

September 2020

Predictors of the trajectory of cognitive functioning in the first 6 months after allogeneic hematopoietic stem cell transplantation.

Authors:

Samantha J Mayo Hans A Messner Sean B Rourke Doris Howell J Charles Victor Jeffrey H Lipton J Kuruvilla Vikas Gutpa Dennis Dong Hwan Kim Fotios V Michelis Kelly Metcalfe

Bone Marrow Transplant 2020 05 19;55(5):918-928. Epub 2019 Nov 19.

Lawrence S. Bloomberg Faculty of Nursing, University of Toronto, Toronto, ON, Canada.

View Article and Find Full Text PDF

May 2020

Allogeneic stem cell transplant in myelodysplastic syndrome-factors impacting survival.

Authors:

Shruti Prem Eshetu G Atenafu Wilson Lam Arjun Law Fotios V Michelis Dennis Kim Auro Viswabandya Jeffrey Howard Lipton Jonas Mattsson Rajat Kumar

Eur J Haematol 2020 Feb 2;104(2):116-124. Epub 2019 Dec 2.

Princess Margaret Cancer Centre, Toronto, ON, Canada.

View Article and Find Full Text PDF

February 2020

My jamais vu in post allogeneic hematopoietic cell transplant: a review on secondary hemophagocytosis in adults.

Authors:

Rehab M Alblooshi Uday Deotare Fotios V Michelis Santhosh Thyagu Dennis Dong Hwan Kim Jeffrey H Lipton Ghada M ElGohary Auro Viswabandya

Bone Marrow Transplant 2020 05 14;55(5):867-872. Epub 2019 Oct 14.

Allogeneic Blood and Marrow Transplant Program, Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.

View Article and Find Full Text PDF

May 2020

Impact of CD34+ cell dose on reduced intensity conditioning regimen haploidentical hematopoietic stem cell transplantation.

Authors:

Maria Queralt Salas Eshetu G Atenafu Maria Rhida Bautista Shruti Prem Wilson Lam Arjun Datt Law Zeyad-Al Shaibani Dennis Dong Hwan Kim Fotios V Michelis Jeffrey Howard Lipton Auro Viswabandya Jonas Mattsson Rajat Kumar

Eur J Haematol 2020 Jan 6;104(1):36-45. Epub 2019 Oct 6.

Section of Medical Oncology and Hematology, Department of Internal Medicine, University of Toronto, ON, Canada.

View Article and Find Full Text PDF

January 2020

Reduced-intensity conditioning allogeneic transplant with dual T-cell depletion in myelofibrosis.

Authors:

Maria Queralt Salas Wilson Lam Arjun Datt Law Dennis Dong Hwan Kim Fotios V Michelis David Loach Zeyad Al-Shaibani Jeffrey Howard Lipton Rajat Kumar Jonas Mattsson Auro Viswabandya

Eur J Haematol 2019 Dec 30;103(6):597-606. Epub 2019 Sep 30.

Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.

View Article and Find Full Text PDF

December 2019

Reduced intensity allogeneic stem cell transplant with anti-thymocyte globulin and post-transplant cyclophosphamide in acute myeloid leukemia.

Authors:

Maria Queralt Salas Shruti Prem Eshetu G Atenafu Arjun Datt Law Wilson Lam Zeyad Al-Shaibani David Loach Dennis Dong Hwan Kim Fotios V Michelis Jeffrey Howard Lipton Rajat Kumar Jonas Mattsson Auro Viswabandya

Eur J Haematol 2019 Nov 9;103(5):510-518. Epub 2019 Sep 9.

Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.

View Article and Find Full Text PDF

November 2019

Impact of central nervous system involvement in AML on outcomes after allotransplant and utility of pretransplant cerebrospinal fluid assessment.

Authors:

Shruti Prem Eshetu G Atenafu Jose Avena Rhida Bautista Arjun Law Wilson Lam Fotios V Michelis Dennis Dong Hwan Kim Auro Viswabandya Jeffrey Howard Lipton Jonas Mattsson Rajat Kumar

Eur J Haematol 2019 Nov 5;103(5):483-490. Epub 2019 Sep 5.

Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada.

View Article and Find Full Text PDF

November 2019

Epstein-Barr virus associated post-transplant lymphoproliferative disorder mimicking acute graft versus host disease.

Authors:

Shruti Prem Zeyad Al-Shaibani Fotios V Michelis Dennis Kim Auro Viswabandya Jeffrey Howard Lipton Rajat Kumar Jonas Mattsson Arjun Law Wilson Lam

Eur J Haematol 2019 Nov 27;103(5):519-522. Epub 2019 Aug 27.

Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada.

View Article and Find Full Text PDF

November 2019

Combination of the Centre for International Blood and Marrow Transplant Registry Risk Score and the Global Severity Score Enhances Prognostic Risk Stratification in Patients Receiving Frontline Therapy for Chronic Graft-versus-Host Disease.

Authors:

Roman M Shapiro Elizabeth Shin Arjun Datt Law Wilson Lam Fotios V Michelis Auro Viswabandya Rajat Kumar Jeffrey H Lipton Hans Messner Jonas Mattsson Dennis Dong Hwan Kim

Biol Blood Marrow Transplant 2019 09 4;25(9):1761-1769. Epub 2019 Jun 4.

Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada. Electronic address:

View Article and Find Full Text PDF

September 2019

Low rates of acute and chronic GVHD with ATG and PTCy in matched and mismatched unrelated donor peripheral blood stem cell transplants.

Authors:

Shruti Prem Eshetu G Atenafu Zeyad Al-Shaibani David Loach Arjun Law Wilson Lam Fotios V Michelis Santhosh Thyagu Dennis Dong Hwan Kim Jeffrey Howard Lipton Rajat Kumar Auro Viswabandya

Eur J Haematol 2019 Jun 29;102(6):486-493. Epub 2019 Apr 29.

Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.

View Article and Find Full Text PDF

June 2019

Influence of FLT3-ITD and NPM1 status on allogeneic hematopoietic cell transplant outcomes in patients with cytogenetically normal AML.

Authors:

Ivan Pasic Waleed Da'na Wilson Lam Arjun Law Jeffrey H Lipton Auro Viswabandya Dennis D Kim Santhosh Thyagu Hans A Messner Fotios V Michelis

Eur J Haematol 2019 Apr 13;102(4):368-374. Epub 2019 Feb 13.

Hans Messner Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada.

View Article and Find Full Text PDF

April 2019

Mobilization of Leukemic Cells Using Plerixafor as Part of a Myeloablative Preparative Regimen for Patients with Acute Myelogenous Leukemia Undergoing Allografting: Assessment of Safety and Tolerability.

Authors:

Fotios V Michelis David W Hedley Sonal Malhotra Sue Chow David Loach Vikas Gupta Dennis D Kim John Kuruvilla Jeffrey H Lipton Auro Viswabandya Hans A Messner

Biol Blood Marrow Transplant 2019 06 14;25(6):1158-1163. Epub 2019 Jan 14.

Messner Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada.

View Article and Find Full Text PDF

June 2019

Reduced-Intensity Conditioning and Dual T Lymphocyte Suppression with Antithymocyte Globulin and Post-Transplant Cyclophosphamide as Graft-versus-Host Disease Prophylaxis in Haploidentical Hematopoietic Stem Cell Transplants for Hematological Malignancies.

Authors:

Arjun Datt Law Maria Queralt Salas Wilson Lam Fotios V Michelis Santhosh Thyagu Dennis Dong Hwan Kim Jeffrey Howard Lipton Rajat Kumar Hans Messner Auro Viswabandya

Biol Blood Marrow Transplant 2018 11 7;24(11):2259-2264. Epub 2018 Aug 7.

Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada. Electronic address:

View Article and Find Full Text PDF

November 2018

Fludarabine and busulfan plus low-dose TBI as reduced intensity conditioning in older patients undergoing allogeneic hematopoietic cell transplant for myeloid malignancies.

Authors:

Manar M I Khalil Hans A Messner Jeffrey H Lipton Dennis D Kim Auro Viswabandya Santhosh Thyagu Uday Deotare Fotios V Michelis

Ann Hematol 2018 Oct 11;97(10):1975-1985. Epub 2018 Jun 11.

Allogeneic Blood and Marrow Transplant Program, Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, 610 University Ave, Toronto, ON, M5G 2M9, Canada.

View Article and Find Full Text PDF

October 2018

Publications by authors named "Fotios Michelis"

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors: